Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The role of coumadin and aspirin in atrial fibrillation.

× No keyword cloud information.

12 in total

1. Echocardiographic and clinical predictors for outcome of elective cardioversion of atrial fibrillation.

Authors: H C Dittrich; J S Erickson; T Schneiderman; A R Blacky; T Savides; P H Nicod
Journal: Am J Cardiol Date: 1989-01-15 Impact factor: 2.778

2. Mitral annular calcification and the risk of stroke in an elderly cohort.

Authors: E J Benjamin; J F Plehn; R B D'Agostino; A J Belanger; K Comai; D L Fuller; P A Wolf; D Levy
Journal: N Engl J Med Date: 1992-08-06 Impact factor: 91.245

3. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.

Authors: P Petersen; G Boysen; J Godtfredsen; E D Andersen; B Andersen
Journal: Lancet Date: 1989-01-28 Impact factor: 79.321

4. Factors determining maintenance of sinus rhythm after chronic atrial fibrillation with left atrial dilatation.

Authors: M A Brodsky; B J Allen; E V Capparelli; C R Luckett; R Morton; W L Henry
Journal: Am J Cardiol Date: 1989-05-01 Impact factor: 2.778

5. Transesophageal echocardiography before and during direct current cardioversion of atrial fibrillation: evidence for "atrial stunning" as a mechanism of thromboembolic complications.

Authors: D Fatkin; D L Kuchar; C W Thorburn; M P Feneley
Journal: J Am Coll Cardiol Date: 1994-02 Impact factor: 24.094

6. The natural history of lone atrial fibrillation. A population-based study over three decades.

Authors: S L Kopecky; B J Gersh; M D McGoon; J P Whisnant; D R Holmes; D M Ilstrup; R L Frye
Journal: N Engl J Med Date: 1987-09-10 Impact factor: 91.245

7. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators.

Authors: M D Ezekowitz; S L Bridgers; K E James; N H Carliner; C L Colling; C C Gornick; H Krause-Steinrauf; J F Kurtzke; S M Nazarian; M J Radford
Journal: N Engl J Med Date: 1992-11-12 Impact factor: 91.245

8. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study.

Authors: S J Connolly; A Laupacis; M Gent; R S Roberts; J A Cairns; C Joyner
Journal: J Am Coll Cardiol Date: 1991-08 Impact factor: 24.094

9. Transesophageal echocardiographically facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: final results of a prospective 4.5-year study.

Authors: W J Manning; D I Silverman; C S Keighley; P Oettgen; P S Douglas
Journal: J Am Coll Cardiol Date: 1995-05 Impact factor: 24.094

10. Risk factors for stroke in patients with nonrheumatic atrial fibrillation: a case-control study.

Authors: A W Moulton; D E Singer; J S Haas
Journal: Am J Med Date: 1991-08 Impact factor: 4.965